Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2300076671Phase 4Recruiting
Phase 4, randomised trial of remimazolam in sepsis (2 arms), sponsored by First Affiliated Hospital of Kunming Medical University. Primary endpoint: RASS Score. Started Oct 2023; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2300076671.